Dr. Hall graduated from the University of North Carolina School of Medicine at Chapel Hill in 1990. He works in Greenwood, SC and specializes in Internal Medicine. Dr. Hall is affiliated with Self Regional Healthcare.
The instant disclosure provides methods and compositions related to discovery that topical administration of MEK inhibitors for the treatment of skin disorders (e.g., skin cancer, inflammatory skin disorders) is accomplished with markedly reduced dosage levels in comparison with oral administration dosage levels. Therapeutic and/or prophylactic uses and compositions of known MEK inhibitors are described.